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A canine skin equivalent model has been validated for the assessment of a topical formulation effects. Skin equivalents were
developed from freshly isolated cutaneous canine fibroblasts and keratinocytes, after enzymatic digestion of skin samples (𝑛 = 8)
from different breeds. Fibroblasts were embedded into a collagen type I matrix, and keratinocytes were seeded onto its surface
at air-liquid interface. Skin equivalents were supplemented with essential oils and polyunsaturated fatty acid formulation or with
vehicle. Skin equivalents were histopathologically and ultrastructurally studied, and the three main lipid groups (free fatty acids,
cholesterol, and ceramides) were analyzed. Results showed that the culture method developed resulted in significant improvements
in cell retrieval and confluence. Treated samples presented a thicker epidermis with increased number of viable cell layers, a denser
and compact stratum corneum, and a more continuous basal membrane. Regarding lipid profile, treated skin equivalents showed
a significant increase in ceramide content (51.7 ± 1.3) when compared to untreated (41.6 ± 1.4) samples. Ultrastructural study
evidenced a compact and well-organized stratum corneum in both treated and control skin equivalents. In conclusion, cell viability
and ceramides increase, after lipid supplementation, are especially relevant for the treatment of skin barrier disruptions occurring
in canine atopic dermatitis.
1. Introduction
In recent years, significant progress has beenmade to produce
engineered substitutes of human and animal skin [1]. Human
skin equivalents (SE) reconstructed from both epidermal
and dermal compartments are currently employed for safety
and toxicity studies in both cosmetics and pharmaceutical
compounds [2].
In veterinary medicine, tissue culture technology has
been mainly applied to the development of in vitro models
of canine skin pathologies such as epidermolysis bullosa [3].
Afterwards, Serra et al. [4] developed an SE from healthy
canine skin suggesting the use of that organotypic skin
culture as an alternative to the in vivo investigations for
skin research. Nevertheless, to our knowledge, there are no
studies evaluating the suitability of canine SE models for
pharmacological compounds testing. A canine SE would
be a useful tool for test topical or systemic treatments in
veterinary medicine contributing to cutaneous drug research
while sparing experimental animals. In this way, it would be
possible to study the effects not only in skin cells but also in
skin morphology and functionality.
Atopic dermatitis (AD) is the most common skin disease
in veterinary medicine and, as other dermatoses, like irritant
dermatitis, allergic contact dermatitis, and ichthyosis, it is
characterized by an epidermal barrier defect [5–8]. Impaired
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skin allows an excessive penetration of allergens andmicroor-
ganisms that may trigger the acute and chronic inflammatory
response of AD [9–12].
Skin barrier defect could be caused by several phenomena
such as a decrease of lipid matrix production from stratum
corneum (SC) or alterations in the relationships between
the three SC major lipids of the matrix (ceramides (CER),
fatty acids (FA) and cholesterol (CHO)) [13–15]. Epidermal
ultrastructural changes have been also related to AD as
abnormal intercorneocyte junctions [12, 16] and abnormal
cellular maturation and differentiation [17–19].
Topical administration or diet supplementation with free
fatty acids (FFA) could stimulate the production of endoge-
nous lipids contributing to the formation and improvement
of epidermal barrier [10, 11, 20–22].
Essential oils and polyunsaturated fatty acids have
demonstrated effective results not only in atopic dogs, show-
ing reduced mean CADESI and pruritus scores [23, 24], but
also in atopic cats [25].
The purpose of the present study was to assess the
suitability of canine SE model as a tool to evaluate the
influence of topical treatments on epidermis development.
With this objective, essential oils and polyunsaturated fatty
acids were used to investigate the changes induced on the
lipid profile, epidermis development, and basal membrane
structure of canine SE.
2. Material and Methods
2.1. Skin Equivalent Development. Cutaneous cells were iso-
lated from fresh skin biopsies obtained from eight healthy
dogs between 1–12 years old. Abdominal samples were taken
from other purposes surgeries at the Veterinary Hospital of
the Universitat Auto`noma de Barcelona. During the present
study, skin samples (𝑛 = 8), obtained from different dog
breeds (Beagle, Great Dane, Weimaraner, West Highland
White Terrier, and crossbreed), were processed.
Samples were washed in phosphate buffered saline, cut
in small fragments (1mm3), and digested with collagenase
type I solution (2mg/mL) in DMEM for 4–6 h at 37∘C until
dermis were totally digested. Collagenase supernatants was
washed and centrifuged at 300 g for 5min, and the obtained
fibroblasts were grown in a humidified atmosphere at 37∘C
with 5% CO
2
during 2 days. Medium was changed twice a
week, and cells were used between passages 2 to 5.
After collagenase digestion, remaining epidermal frag-
ments were washed and digested with a solution of 0.05%
trypsin-0.02% EDTA during 30min at 37∘C, in order to
obtain a high pure culture of keratinocytes. Trypsin super-
natants were filtered twice with cell strainers (100 𝜇m and
40 𝜇m pore size, resp, BD Biosciences, Bedford, MA, USA)
and centrifuged at 300 g for 5min to recover keratinocytes.
Primary keratinocytes (1 × 106 cells/cm2) were plated
in collagen coated flasks with mitomycin C-inactivated 3T3
cell feeder layer in a humidified atmosphere at 37∘C with
5% CO
2
for 1 week in DMEM/F12 (3 : 1) with 10% FCS
(Gibco), 10−6M hydrocortisone, 10−6M isoproterenol, and
10−7M insulin (Sigma).
To obtain a three dimensional SE, 3mL of rat tail type
I collagen solution (1.5mg/mL solution) containing 1.2 ×
105 fibroblasts were placed in a transwell chamber (Corning
Tewksbury, MA, USA). The biomatrix was cultured for 5–7
days, and then 5 × 105 keratinocytes were seeded onto its sur-
face. After 24 hours, SEs were lifted at the air-liquid interface,
and the medium was modified by including 1% of FCS, L-
serine 0.1%, FFA (15 𝜇M linoleic acid, 7𝜇M arachidonic acid,
and 25 𝜇M palmitic acid), 50𝜇g/mL ascorbic acid, 1 𝜇M DL-
𝛼-tocopherol-acetate, and 2.4 × 10−5MBSA (all of them from
Sigma). Skin equivalents were cultured for 48 h, and then the
same medium but without FCS and 30 𝜇M linoleic acid was
used. Skin equivalents were cultured, a total of 14 days at air-
liquid interface, and medium was changed twice a week.
2.2. Skin Equivalent Treatments. A total of 22 SEs were
developed, 13 treated and 9 controls. Seven days after seeding
the keratinocytes, SEsmediumwere supplementedwith 10𝜇L
(1% in 9% ethanol aqueous solution/mL of culture medium)
of essential oils and polyunsaturated fatty acids formulation,
Rosmarinus officinalis leaf oil, Lavandula hybrida oil, Eugenia
caryophyllus bud oil,Melaleuca alternifolia leaf oil, Cinnamo-
mum camphora leaf oil,Mentha piperita oil, Cedrus atlantica
bark oil, Curcuma longa root oil, Origanum compactum oil,
Gaultheria procumbens leaf oil,Cannabis sativa seed oil,Melia
azadirachta seed oil (Dermoscent Essential 6, Laboratoire
de Dermo-Cosme´tique Animale, France). Control SEs were
developed in the identical condition but treated with vehicle.
2.3. Histopathological Study. A total of 12 SEs were used
to perform the histopathological studies: 7 treated and 5
controls. Skin equivalents and healthy canine skin as control
were fixed in 10% formalin and embedded in paraffin wax.
Sections (4𝜇m)were cut and stained by routinemethodswith
hematoxylin and eosin (H&E). Moreover, pancytokeratin
(cytokeratins 5, 6, 8, and 17–19), collagen type IV, laminin
5, and vimentin were used to characterize the structure of
epidermis, dermis, and basement membrane in SE models.
After deparaffinization and hydration, samples were
treated with 3% H
2
O
2
(33%) to inhibit the endogenous
peroxidase, and the nonspecific sites were blocked with
2% BSA in TBS for 1 h at RT before the addition of each
primary antibody. The primary antibodies used, with the
corresponding pretreatment for antigen retrieval and dilution
conditions, were mouse anti-pancytokeratin (pretreatment
of 0.01% trypsin for 20min at RT, 1 : 25 dilution, Clone
MNF116; Dako, Carpinteria, CA, USA), goat anti-collagen IV
(pretreatment of protease type XIV for 8min at 37∘C, 1 : 100
dilution; Southern Biotechnology, Birmingham, AL, USA),
rabbit anti-laminin 5 (pretreatment of 0.1% proteinase K for
8min at 37∘C, 1 : 800 dilution; Dako, Carpinteria, CA, USA),
and mouse anti-vimentin (pretreatment of citrate buffer for
20min at 98∘C plus 30min at RT, 1 : 50 dilution, Clone V9;
Dako, Carpinteria, CA, USA). After incubation with the
corresponding primary antibody (16 h at 4∘C), samples were
processed using a streptavidin-biotin complex. Secondary
biotin-labelled antibodies used were goat anti-mouse IgG
for pancytokeratin and vimentin, a rabbit anti-goat IgG for
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Figure 1: Histological sections of canine healthy skin (a) and canine skin equivalent (b) (400x).
collagen IV, and a goat anti-rabbit IgG for laminin 5. All the
secondary antibodies were used at a 1 : 200 dilution in TBS
for 1 h at RT and were from Dako (Carpinteria, CA, USA).
Diaminobenzidine (DAB) was used as the detection system
and, finally, samples were counterstained with haematoxylin.
2.4. Functional Study: Lipid Quantification. Two weeks after
starting the treatment, SEs were removed and the lipid profile
was assessed. A total of 10 SEs were used, 6 SEs supplemented
with the essential oils and polyunsaturated fatty acids for-
mulation and 4 controls. Treated SEs were harvested, and
material from the epidermis and dermis compartment was
extracted according to Bligh and Dyer method [26]. Briefly,
lipids were extracted from the epidermis at RT by stirring
with different mixtures of chloroform/methanol 2 : 1, 1 : 1, and
1 : 2 for 2 hours each. Samples were dried with nitrogen and
dissolved again in chloroform/methanol 2 : 1.Thequantitative
analyses of lipids from obtained extracts were performed by
thin layer chromatography coupled to an automated ioniza-
tion detector (IatroscanMK-5 analyzer, Iatron, Tokyo, Japan).
Samples were applied on Silica gel S-III Chromarods using
a SES (Nieder-Olm, Germany) 3202/15-01 sample spotter.
Before performing a total scan, the rods were developed
to a distance of 2.5 cm with chloroform/methanol/water
(57 : 12 : 0.6), to 8 cm with hexane/diethyl ether/formic acid
(50 : 20 : 0.3), and finally to 10 cm with hexane/benzene
(35 : 35) [27].
The total lipidswere separated in the following 3 fractions:
CHOL, FFA, and CER. For each sample the analyses were
performed in duplicate.
2.5. Ultrastructural Study: Electron Microscopy. Six canine
SEs were processed for electron microscopy to evaluate the
ultrastructure in control (𝑛 = 3) and treated samples
(𝑛 = 3). Samples were immersed in a fixative solution of
2% (w/v) paraformaldehyde (EM grade, Merck, Darmstadt,
Germany) and 2.5% (v/v) glutaraldehyde (EM grade, TAAB
Laboratories, Berkshire, UK) in phosphate buffer (PBS; 0.1M,
pH 7.4; Sigma Aldrich, Steinheim, Germany) for 2 h.
Following fixation, the samples were rinsed four times
with 100mM PBS. Samples were then postfixed in 1% (w/v)
osmium tetroxide (TAAB) containing 0.8% (w/v) potassium
hexacyanoferrate (III) (Sigma, Madrid, Spain) for 2 h and
washed with deionized water four times and sequential
dehydration in acetone. All procedures were performed at
4∘C. Samples were dehydrated through a graded acetone
series, embedded in Eponate 12 resin (Ted Pella Inc., Redding,
California), and polymerized for 48 h at 60∘C.
Semithin sections (1mm thick) were obtained with a
Leica ultracut UCT microtome (Leica Microsystems GmbH,
Wetzlar, Germany), stained with 1% (w/v) aqueous toluidine
blue solution, and examined with a light microscope to
identify areas for the following steps.
Ultrathin sections (70 nm in thickness) were cut with a
diamond knife (45∘, Diatome, Biel, Switzerland), mounted in
copper grids (200mesh), and contrasted with conventional
uranyl acetate (30min) and Reynolds lead citrate (5min)
solutions. Sections were observed with a Jeol 1400 transmis-
sion electron microscope (Jeol Ltd, Tokyo, Japan) equipped
with aGatanUltrascanES1000CCDCamera (Gatan, Inc. CA,
USA).
2.6. Statistical Study. Statistical significance of the results was
determined using the two tailed Student’s t-test for unpaired
data (𝑃 < 0.05 and 𝑃 < 0.01).
3. Results
3.1. Skin Equivalent Obtaining. Keratinocyte isolation after
collagenase digestion showed higher recovery rates than
dispase digestion obtained in our lab previously (unpublished
results). Hence, with collagenase digestion, a mean of 19.3
× 106 cells/gr of skin was obtained whilst dispase digestion
mean recovery was 4.8 × 106 cells/gr of skin. In the same
way, collagen coated flasks and coculture with mitomycin C-
inactivated 3T3 feeder layer improved cell growth and full
confluence achievement were obtained in a shorter period
(7–9 days versus 14-15 days). This new technique allowed
the establishment of several pure keratinocytes lines, with no
fibroblast contamination and high viability rates (96–98%).
3.2. Histopathological Study. The structure of the SEs, der-
mis and epidermis, was analysed after hematoxylin-eosin
staining. Canine skin equivalents presented a similar mor-
phological structure than healthy canine skin (Figure 1) as
it was demonstrated in a previous study performed in our
laboratory [4].
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Figure 2: Morphological analysis of control and treated skin equivalents (400x).
Histological analysis showed an epithelial architecture
resembling native skin with formation of a mature dermis
and multilayered and differentiated epidermis, including
the basal, spinous, and granular layers and a flattened
stratum corneum in the overall SEs studied. As shown
in Figures 2(a) and 2(b), differentiation and maturation
of the dermis-equivalent (collagen gel biomatrix) and the
epidermis-equivalent (keratinocytes layers), as well as the
dermoepidermal junction, were correctly developed in both
control and treated SEs.
When essential oils and polyunsaturated fatty acids for-
mulation were included in the medium, several differences
were observed. In treated SEs, a more continuous basal
membrane and an increase in number of keratinocyte layers
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Figure 3: Chromatography study of the different lipid fractions of non-treated skin equivalents (a), essential oils and polyunsaturated fatty
acids treated skin equivalents (b), and standard lipid profile (c).
was evidenced. Moreover, the SC was more dense and
compact in treated SEs.
The characterization of keratinocytes in basal and
suprabasal layers of the SEs was performed by the immun-
odetection with pancytokeratin. The expression of specific
epitopes of keratins was recognized in the cellular mem-
brane by pancytokeratin antibody, demonstrating the correct
maturation of the epidermis in SEs (Figures 2(c) and 2(d)).
Moreover, the lack of reactivity of pancytokeratin antibody
in the collagen gel bio-matrix agreed with the absence of
cytokeratins expression in native dermis.
The identification of fibroblasts of the SEs was performed
by immunodetection of vimentin, a specific marker of mes-
enchymal cells, like fibroblasts. Vimentin-immunoreactivity
was detected in the SE dermis in both, non-treated and
treated samples, showing a properly structured, active, and
mature dermis (Figures 2(e) and 2(f)). The lack of reactivity
of vimentin antibody in keratinocyte layers agreed with
nonexpression of vimentin in native epidermis.
The development of a continuous basal membrane in
dermoepidermal junction of SEs is observed in Figures 2(g)
and 2(j). The presence and localization of the major basal
membrane components, such as collagen type IV and laminin
5, were detected by immunohistochemistry. As shown in
both control and treated SEs, a well defined membrane
was observed; however, in treated samples the membrane
thickness was higher than in non-treated skins especially for
collagen type IV (Figure 2(h)).
3.3. Lipid Quantification. Samples obtained from canine SEs
were analysed for lipid quantification. Lipids were separated
in the following fractions: CHOL, FFA, and CER.
In Figure 3 the chromatographic lipid profile of both
treated and non-treated SEs can be observed.
Table 1: Percentage of different lipid fractions obtained from the
skin equivalents in control (𝑛 = 4) and treated samples (𝑛 = 6).
Lipid fractions (%) of skin equivalents
Lipid profile Control(MEAN ± SEM)
Treated
(MEAN ± SEM)
FFA 21.6 ± 1.1 15.9 ± 1.3∗∗
CHOL 36.7 ± 1.5 32.4 ± 1.7
CER 41.6 ± 1.4 51.7 ± 1.3∗∗
∗∗
𝑃 < 0.01.
Table 1 shows the percentage of different lipid fractions
obtained from the lipid extract of canine SEswith andwithout
treatment. As observed, when canine SEs were treated with
the essential oils and polyunsaturated fatty acids formulation,
the ceramide percentage was significantly higher (51.7 ± 1.3)
compared to that in control samples (41.6 ± 1.4). Moreover,
a significant decrease in FFA was observed in treated skin
samples.
3.4. Ultrastructural Study. Ultrastructural morphology of
four SEs was examined by transmission electron microscopy.
Untreated and treated SEs presented thick andwell developed
desmosomes between corneocytes in the different strata
(Figures 4(a) and 4(d)). In dermal-epidermal junction, a
continuous basal membrane with both densa and lucida
laminae was observed. Moreover, hemidesmosomes between
basal corneocytes and basalmembranewere observed in both
treated and non-treated samples (Figures 4(b) and 4(e)).
Stratum corneum was also well-organized, compact, and
dense with almost entirely fulfilment of intercorneocyte
spaces (Figures 4(c) and 4(f)) in both, treated and non-
treated samples. Even though no morphological differences
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Figure 4: Ultrastructural images of non-treated (a, b, c) and treated skin equivalent with essential oils and polyunsaturated fatty acids (d, e
and f). Desmosomes between adjacent corneocytes (a, c) (white arrows), hemidesmosomes (b, e) (black arrows), and stratum corneum with
vertical cohesion between corneocytes layers (white arrow head) (c, f) were observed in both samples. Scale bars: 5𝜇m (a and d), 0.5 𝜇m (b),
1 𝜇m (c and f), and 0.2 𝜇m (e).
were observed between samples, during TEM sample pro-
cessing, samples treated with essential oils presented a more
resistant SC bindings than control samples that were often
separated from the upper layers of epidermis, while in treated
samples SC was always attached to epidermis.
4. Discussion
The results shown in the present study demonstrated the
suitability of canine SE model to investigate the effects of
topical essential oils and polyunsaturated fatty acids, in
canine epidermis. In the present study, the structure and
lipid composition were also analysed. A significant increase
in CER concentration of SE lipids was observed after the
treatment.
Skin equivalents have been developed and investigated
over the past years for their applications in human medicine
for skin biology research [28, 29], cutaneous irritation, and
toxicity testing [30, 31], and as experimental models for
permeability and cutaneous absorption of different agents
and formulations [18, 32]. On the contrary, in veterinary
medicine, little information is published regarding SEs.
Canine organotypic skin cultures have been developed for
skin dysfunctions studies, such as epidermolysis bullosa or
k10 lack-keratinisation defect [3, 33]. These canine SEs were
designed as disease research-models. The characterization of
healthy canine SE model was not performed until 2007. Serra
et al. developed a canine SE from healthy skin suggesting the
use of that organotypic skin culture as an alternative to in vivo
investigations for skin research. In the present study, several
changes have been incorporated in the model described by
Serra et al. [4] in order to optimize the technique.
First of all, regarding the obtaining method, the isolation
of keratinocytes after dermal collagenase separation showed
in the present study resulted in increased recovery rates when
compared with the classical dispase digestion, probably due
to higher hair follicle stem cell retrieval. This hypothesis
is based on the fact that epidermis-dermis separation with
dispase requires epidermis sheet to be mechanically peeled
from the dermis, and probably a high percentage of hair
follicles remains in the dermis portion. Contrarily, by using
collagenase in the process, dermis is first digested, and then
the resultant fraction is composed by the total epidermis,
including hair follicles with proper stem cells. Another
improvement achieved through the present method was the
coculture of keratinocytes withmitomycin C-inactivated 3T3
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feeder layer in collagen coated flasks that showed a shorter
confluence period in primary cultures in comparison with
noncoated flasks used by Serra et al. [4]. Therefore, in this
study, keratinocytes isolation and culture has been optimized
regarding the primitive model allowing easier and faster SE
obtaining.
This improved SE has been used to test the effects of a
lipidic formulation for the improvement of canine skin con-
dition. With this purpose, the lipidic compound was added
to the SE growth medium in order to determine its effects
in basal layers development, maturation, and differentiation.
Protein expression and healthy skin ultrastructure were not
altered by lipid supplementation in growth medium, but an
increase in the number of epidermal layers in treated samples
was observed, probably due to an increase in the viability.This
hypothesis agrees with previous studies evidencing fatty acid
supplementation in culture media improves cell growth and
promotes epithelial morphogenesis in SEs [28, 34].
As described previously, modifications in culture media
can lead to changes not only in the differentiation process
but also in lipid profile of the SE [28, 32, 35, 36]. In the
present study, three lipidic groups were analyzed (CHOL,
FFA, and CER). Essential oils and polyunsaturated fatty acids
supplementation induced an increase in the CER proportion
of epidermal lipids. Fatty acid supplementation has already
been described to promote CER synthesis since CER are
generally composed of a sphingoid base and fatty acids [28,
37, 38]. This point is important since CER level has been
demonstrated to be decreased in diseases related to impaired
skin barrier such as AD [14, 39–41]. Moreover, essential fatty
acids can reduce allergic inflammation response through
the modulation of prostaglandin and leukotriene production
[42, 43] and the inhibition of cellular activation and cytokine
secretion [44], as well as the alteration of the composition
and function of the epidermal lipid barrier [11]. Therefore,
the results of the present study agree with previous studies
where topical and dietary administration of essential oils and
polyunsaturated fatty acids have been closely related to the
improvement of the lipidic matrix of canine atopic skin and
its symptomatology [11, 22, 23, 45, 46].
Although FFA were present in the topical formula used
for the treatment, their levels decreased in treated SEs
samples. This result suggests FFA incorporation to the SE
lipids as the substrate for the CER synthesis or by binding
to epidermal proteins as it has been described previously [18,
47]. In fact, FFA reduction observed in treated samples was
not reflected in an alteration of SC structure since electron
micrographs showed compact and dense lipid lamella in
treated as in control SEs.
In the present study, the effects of essential oils and
polyunsaturated fatty acids were studied in a healthy SE
model. So, the effects of lipidic supplementation would
be more evident and the clinical benefit would be more
measurable if AD animals with skin barrier dysfunction and
epidermal lipid disorders were used. However, canine SE is
a useful model to evaluate and to extrapolate the activity
of exogenous compounds such as lipidic formulations on
epidermal lipid matrix and the potential contribution of such
active molecules, avoiding the use of live dogs.
In this study we described for the first time the suitability
of canine SE for testing topical treatments contributing to
cutaneous drug researchwhile sparing experimental animals.
With thismodel it is possible to test the effects not only in skin
cells but also in skin morphology, functionality, and changes
in extracellular lipid composition.
In conclusion, the purposes of this study have been
achieved since the SE has showed to be an appropriate
model for the study of dog skin. Moreover, this canine SE
model enables the study of the effects of compounds such
as essential oils and polyunsaturated fatty acids, showing
an increase in CER content of intercellular lipid domain of
SC, which becomes particularly relevant in the treatment of
atopic dermatitis and other lipid barrier dysfunctions.
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